Genmab — Maj 2020
-
Dittor here.
-
Kæmpe kurs-milepæl opnået, og dermed en lille donation fra mig også
-
...og kæmpe tak for en sober og særdeles vel-informativ chat herinde, allesammen!
-
that BMS Covid trial with BMS-986253 is not only for cancer patients anymorel, they broadened it to all patients with Covid
https://clinicaltrials.gov/ct2/history/NCT04347226?A=2&B=3&C=merged#StudyPageTop -
they just increased the trial size of the 2nd trial from 20 to 120
https://clinicaltrials.gov/ct2/history/NCT04077463?A=5&B=6&C=merged#StudyPageTop -
this is the first trial , also slightly enlarged https://clinicaltrials.gov/ct2/history/NCT02609776?A=44&B=45&C=merged#StudyPageTop
-
small new
trial : A Phase II Trial for the Treatment of POEMS Syndrome With Daratumumab https://clinicaltrials.gov/ct2/show/NCT04396496?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=05%2F19%2F2020&draw=2&rank=1 -
Fate Therapeutics plans to initiate clinical investigation of FT538 in combination with daratumumab, for the treatment of multiple myeloma. https://www.globenewswire.com/fr/news-release/2020/05/20/2036323/0/en/Fate-Therapeutics-Announces-FDA-Clearance-of-IND-Application-for-FT538-First-CRISPR-edited-iPSC-derived-Cell-Therapy.html https://fatetherapeutics.com/pipeline/immuno-oncology-candidates/ft538/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind